| Six months ended | Year ended | ||
| 30 September | 31 March | ||
| 2007 | 2006 | 2007 | |
| Rm | Rm | Rm | |
| Sales | 4 624 | 3 755 | 7 872 |
| Inventory expenses | (3 015) | (2 342) | (4 781) |
| Personnel costs | (810) | (677) | (1 302) |
| Depreciation | (129) | (110) | (223) |
| Other net operating expenses | (190) | (187) | (550) |
| Trading profit | 480 | 439 | 1 016 |
| Dividends received | 188 | 79 | 156 |
| Interest received | 165 | 206 | 332 |
| Finance costs | (9) | (15) | (28) |
| Negative goodwill | - | - | 44 |
| Net impairment of investments, assets and goodwill | 6 | - | - |
| Profit on redemption and sale of investments | 96 | 6 | 7 |
| Consolidated profit before tax | 926 | 715 | 1 527 |
| Taxation | (194) | (211) | (403) |
| Consolidated profit after tax | 732 | 504 | 1 124 |
| Share of after-tax profit of associated companies and joint | |||
| Ventures | 3 681 | 2 698 | 6 003 |
| Net profit | 4 413 | 3 202 | 7 127 |
| Attributable to: | |||
| Equity holders | 4 347 | 3 136 | 6 942 |
| Minority interests | 66 | 66 | 185 |
| 4 413 | 3 202 | 7 127 | |
| Share of after-tax profit of associated companies and joint ventures | |||
| Profit before taking into account impairments, non-recurring | |||
| and capital items | 3 561 | 2 789 | 5 995 |
| Net impairment of investments, assets and goodwill | (18) | 7 | (12) |
| Profit on the sale of investments | 174 | 26 | 249 |
| Restructuring costs | (46) | (142) | (237) |
| Other non-recurring and capital items | 10 | 18 | 8 |
| 3 681 | 2 698 | 6 003 | |